Search results
CD7 expression tied to poorer outcomes with newly diagnosed leukemia
Medical Xpress· 1 day agoCD7 expression is associated with poorer outcomes in patients with newly diagnosed acute myeloid ...
Senti Biosciences reports breakthrough in AML treatment By Investing.com
Investing.com· 6 days agoThis data, which was recently published in the journal Cell Reports, highlights the ability of...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Morningstar· 6 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer...
Benzinga· 7 days agoMorphoSys AG MOR is reportedly facing a burgeoning safety concern surrounding pelabresib, an...
Grandmother, granddaughter fight cancer together
The Port Lavaca Wave· 4 days agoWhen faced with cancer at the same time, a grandmother and her grandchild are strengthening their bond as they fight together. Calhoun High School...
Laura Dillard
The World· 3 days agoJames Episcopal Church. It is with heartfelt sadness that we announce the passing of Laura Michelle Dillard who left us peacefully on April 8, 2024,...
Remix Therapeutics Announces First Patients Dosed in Two Phase 1 Clinical Trials Investigating...
CBS 47 Fresno· 4 days agoRemix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, today announced the ...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition
Investing.com· 7 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Finalists named for 2024 Cincy Inno Fire Awards
The Business Journals· 4 days agoStartups provide a certain spark to the Cincinnati economy, and Cincy Inno is ready to honor dozens of the region’s hottest, fastest-growing and most...
Vor Bio appoints new board member with oncology expertise By Investing.com
Investing.com· 3 days agoVor Bio (NASDAQ:VOR), a biotechnology firm specializing in cell and genome engineering, announced...